Network Pharmacology-Based Combined with Experimental Validation Study to Explore the Underlying Mechanism of Agrimonia pilosa Ledeb. Extract in Treating Acute Myocardial Infarction
DOI: https://doi.org/10.2147/DDDT.S370473
2022-09-16
Abstract:Muqing Zhang, 1, 2, &ast Jian Chen, 3, 4, &ast Yanwei Wang, 2 Guobin Kang, 2 Yixin Zhang, 3, 4 Xue Han 3, 4 1 College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China; 2 Affiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China; 3 School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China; 4 International Joint Research Center on Resource Utilization and Quality Evaluation of Traditional Chinese Medicine, Shijiazhuang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yixin Zhang; Xue Han, Tel +86 311 89926316, Fax +86 311 89926316, Email ; Purpose: The network pharmacology approach and validation experiment were performed to investigate the potential mechanisms of Agrimonia pilosa Ledeb . (APL) extract against acute myocardial infarction (AMI). Methods: The primary compounds of APL extract were identified by High-Performance Liquid Chromatography (HPLC) analysis. The intersecting targets of active compounds and AMI were determined via network pharmacology analysis. A mouse model of AMI was established by subcutaneous injection of isoproterenol (Iso). Mice were treated with APL extract by intragastric administration. We assessed the effects of APL extract on the electrocardiography (ECG), cardiac representative markers, representative indicators of oxidative stress, pathological changes, and phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) signaling pathway, as well as apoptosis-related indicators in the mice. Results: Five candidate compounds were identified in APL extract. Enrichment analyses indicated that APL extract could exert myocardial protective effects via the PI3K/Akt pathway. ST segment elevation and increased heart rate were obviously reversed in APL extract groups compared to Iso group. We also detected significant decreases in lactate dehydrogenase (LDH), creatine kinase (CK), creatine kinase MB (CK-MB), malondialdehyde (MDA), and reactive oxygen species (ROS), as well as a significant increase in superoxide dismutase activities (SOD) after APL extract treatment. In addition, APL extract markedly decreased the number of apoptotic cardiomyocytes after AMI. In the APL extract groups of AMI mice, there were increased expression levels of p-PI3K, p-Akt, and B-cell lymphoma-2 (Bcl-2) protein, and there were decreases in Bcl-2-associated X (Bax), cysteinyl aspartate-specific proteases-3 (caspase-3), and cleaved-caspase-3 protein expression levels, as well as the Bax/Bcl-2 ratio. Conclusion: APL extract had a protective effect against Iso-induced AMI. APL extract could ameliorate AMI through antioxidant and anti-apoptosis actions which may be associated with the activation of the PI3K/Akt signaling pathway. Keywords: acute myocardial infarction, APL extract, isoproterenol, oxidative stress, apoptosis, PI3K/Akt Acute myocardial infarction (AMI) involves myocardial necrosis due to persistent and acute ischemia and hypoxia in the coronary arteries, which can cause heart failure in severe cases. 1 AMI is one of the main factors leading to death in patients with cardiovascular diseases. 2 One effective treatment involves timely opening of occluded coronary arteries to restore blood flow. 3 The principles of therapy are to remedy the dying myocardium, minimize the infarct size, protect heart function, and promptly manage all types of complications. Ischemic myocardium can be restored to normal perfusion, but reperfusion can aggravate injury if performed late after ischemia. 4 When the blood supply from the coronary artery cannot meet the myocardial demand, a series of damaging changes occurs, such as myocardial ultrastructural changes, myocardial cell metabolic imbalance, excessive oxidative stress, and myocardial cell necrosis. 5 Serious cases may be life-threatening due to arrhythmia or shock. Isoproterenol (Iso)-induced AMI has become one of the most characteristic models commonly used to evaluate cardioprotective drugs. 6 Iso is a β-receptor agonist which can increase myocardial oxygen consumption by enhancing myocardial contraction and heart rate, causing cardiac overload, impairment of myocardial microcirculation, and myocardial infarction. The pathogenesis of Iso-induced AMI mice is related to oxidative stress and apoptosis. 7 Apoptosis is a process of autonomous and orderly cell death that is controlled by genes and influenced by changes in the internal environment.<su -Abstract Truncated-